| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |